L-erythro-methoxamine is more potent than phenylephrine in effecting contraction of internal anal sphincter in vitro

British Journal of Surgery

Volumn 90, Issue 7, 2003, Pages 872-876

  Jones, O M ^a   Thompson, J M ^b   Brading, A F ^a   Mortensen, N J McC ^c  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b MOUNT VERNON HOSPITAL   (United Kingdom)

^c JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; METHOXAMINE; METHOXAMINE RACEMATE; PHENYLEPHRINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANUS SPHINCTER; ARTICLE; BLOOD PRESSURE; BURNING SENSATION; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONCENTRATION RESPONSE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG ABSORPTION; DRUG EFFECT; DRUG EFFICACY; DRUG FORMULATION; DRUG MEGADOSE; DRUG POTENCY; DRUG SCREENING; FECES INCONTINENCE; GEL; HUMAN; IN VITRO STUDY; IN VIVO STUDY; ISOMER; NONHUMAN; PRIORITY JOURNAL; PULSE RATE; SIDE EFFECT; SWINE;

ADRENERGIC ALPHA-AGONISTS; ANAL CANAL; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; METHOXAMINE; MUSCLE CONTRACTION; PHENYLEPHRINE; PRESSURE; STEREOISOMERISM; SWINE;

EID: 0037998837     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1002/bjs.4120     Document Type: Article

References (19)

1. Kamm MA. Obstetric damage and faecal incontinence. Lancet 1994; 334: 730-733.
2. Vaizey CJ, Kamm MA, Gold DM, Bartram CI, Halligan S, Nicholls RJ. Clinical, physiological and radiological study of a new purpose-designed artificial bowel sphincter. Lancet 1998; 352: 105-109.
3. Jorge JM, Wexner SD. Etiology and management of fecal incontinence. Dis Colon Rectum 1993; 36: 77-97.
4. Mortensen N, Humphreys MS. The anal continence plug: a disposable device for patients with anorectal incontinence. Lancet 1991; 338: 295-297.
5. Musial F, Enck P, Kalveram KT, Erckenbrecht JF. The effect of loperamide on anorectal function in normal healthy men. J Clin Gastroenterol 1992; 15: 321-324.
6. Cook TA, Mortensen NJMcC. Management of faecal incontinence following obstetric injury. Br J Surg 1998; 85: 293-299.
7. Deen KI, Kumar D, Williams JG, Grant EA, Keighley MRB. Randomized trial of internal anal sphincter plication with pelvic floor repair for neuropathic fecal incontinence. Dis Colon Rectum 1995; 38: 14-18.
8. Malouf AJ, Vaizey CJ, Nicholls RJ, Kamm MA. Permanent sacral nerve stimulation for fecal incontinence. Ann Surg 2000; 232: 143-148.
9. Baeten CG, Konsten J, Spaans F, Visser R, Habets AM, Bourgeois IM et al. Dynamic graciloplasty for treatment of faecal incontinence. Lancet 1991; 338: 1163-1165.
10. O'Kelly TJ, Brading A, Mortensen NJMcC. In vitro response of the human anal canal longitudinal muscle layer to cholinergic and adrenergic stimulation: evidence of sphincter specialization. Br J Surg 1993; 80: 1337-1341.
11. Brading AF, Sibley GN. A superfusion apparatus to study field stimulation of smooth muscle from mammalian urinary bladder. J Physiol 1983; 334: 11P-12P.
12. Stebbing JF. Nitric oxide synthase neurones and neuromuscular behaviour of the anorectum. Ann R Coll Surg Engl 1998; 80: 137-145.
13. Carapeti EA, Kamm MA, Evans BK, Phillips RKS. Topical phenylephrine increases anal sphincter resting pressure. Br J Surg 1999; 86: 267-270.
14. Cheetham MJ, Kamm MA, Phillips RKS. Topical phenylephrine increases anal canal resting pressure in patients with faecal incontinence. Gut 2001; 48: 356-359.
15. Speakman CT, Hoyle CH, Kamm MA, Henry MM, Nicholls RJ, Burnstock G. Adrenergic control of the internal anal sphincter is abnormal in patients with idiopathic faecal incontinence. Br J Surg 1990; 77: 1342-1344.
16. Carapeti EA, Kamm MA, Phillips RKS. Randomized controlled trial of topical phenylephrine in the treatment of faecal incontinence. Br J Surg 2000; 87: 38-42.
17. Carapeti EA, Kamm MA, Nicholls RJ, Phillips RKS. Randomized, controlled trial of topical phenylephrine for faecal incontinence in patients after ileoanal pouch construction. Dis Colon Rectum 2000; 43: 1059-1063.
18. Fraunfelder FT, Scafidi AF. Possible adverse effects from topical ocular 10% phenylephrine. Am J Ophthalmol 1978; 85: 447-453.
19. Anibarro B, Barranco P, Ojeda JA. Allergic contact blepharoconjunctivitis caused by phenylephrine eyedrops. Contact Dermatitis 1991; 25: 323-324.